A methylation classifier for detection of hpv-induced invasive cancers, nonhpv- induced gynaecological and anogenital cancers and their high-grade precursor lesions
A technology for precancerous lesions and gynecological cancers, applied in the field of markers for premalignant lesions, can solve the problem of low sensitivity of endometrial cancer detection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0099] Example 1. Discovery of LHX8, ASCL1 and ST6GALNAC5 as useful for detecting cervical cancer and Optimal panel of methylation markers for precancerous lesions
[0100] A comprehensive analysis of genome-wide DNA methylation changes detectable in autologous samples and associated with cervical carcinogenesis has been performed by means of Infinium 450K BeadChip arrays on hrHPV-positive autologous samples. The included sample series consisted of 68 hrHPV-positive autologous samples from 39 women with high-grade cervical intraepithelial neoplasia grade 3 (CIN3) and 29 women with low-grade cervical intraepithelial neoplasia grade 0 or 1 (≤CIN1) composition. The InfiniumHumanMethylation450 BeadChip array analyzes more than 485,000 methylation sites per sample at single-nucleotide resolution in the human genome (Illumina, San Diego, CA, USA). With this approach, we identified 12 methylated targets specifically associated with the presence of CIN3. Next, multiplex qMSP ass...
Embodiment 2
[0103] Example 2 Validation of methylation classifiers in lavage and brush autologous samples
[0104] To validate the clinical performance of the methylation classifier, we analyzed another independent large series of hrHPV-positive lavage autologous samples (n = 198) and brush autologous samples (n = 278) using the multiplex qMSP assay. As observed in the above sample series, the methylation classifier showed good and comparable clinical performance for CIN3 detection for both hrHPV positive lavage (AUC=0.88) and brushing (AUC=0.90) autologous samples (See Figure 4ROC curve of C). In the validation set, 74% (26 of 35) of lavage autologous samples and 88% (49 of 56) of brushing autologous samples from women with CIN3 showed methylation positivity, in hrHPV-positive The corresponding specificities in controls were 79% and 81%, respectively.
Embodiment 3
[0105] Example 3. Methylation of LHX8, ASCL1 and ST6GALNAC5 as used in autologous cervicovaginal samples Markers for primary screening
[0106] Methylation markers tested so far are not well suited for primary screening as specificity is too low at acceptable sensitivity for CIN2 / 3 and cancer. When evaluating the use of a methylation classifier consisting of LHX8, ASCL1, and ST6GALNAC5 as markers for primary screening, it was surprisingly found that when analyzing autologous HPV-negative samples and autologous samples from women with CIN3, the classifier was The detection of CIN3 also had a very high AUC of 0.895 on autologous lavage samples, as well as on autologous brushing samples (AUC was 0.828).
[0107] The present findings indicate that methylation classifiers that detect hypermethylation of the genes LHX8, ASCL1, and ST6GALNAC5 and their regulatory sequences, when applied not only to autologous cervicovaginal douche samples, but also to autologous Potential CIN2+ ...
PUM
Property | Measurement | Unit |
---|---|---|
Sensitivity | aaaaa | aaaaa |
Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com